SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Summer Interns

IP-Watch interns talk about their Geneva experience in summer 2013. 2:42.

Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Analysis: Monkey In The Middle Of Selfie Copyright Dispute

The recent case of a monkey selfie that went viral on the web raised thorny issues of ownership between a (human) photographer and Wikimedia. Two attorneys from Morrison & Foerster sort out the relevant copyright law.


Latest Comments
  • are you aware that within the photographic industr... »
  • A VPN is a virtual private network, which generall... »

  • For IPW Subscribers

    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >


    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >

    Public Health

    16/05/2014: WHO Report Compares Prices, IP Status Of HIV Treatment In Middle-Income Countries
    16/05/2014: IP, R&D Among Issues In Packed Agenda Of 2014 World Health Assembly
    13/05/2014: IP-Watch Subscribers – Updated List Of IP Delegates In Geneva
    13/05/2014: Special Report – Students To Universities: “We Have A Drug Problem”
    09/05/2014: Panel: Good Governance Is Key To Achieving Global Health Goals
    05/05/2014: Panel Looks At Ethical Implications Of Big Data In Health
    01/05/2014: UNCTAD Review Of Bangladesh Calls For Drug Market Opening
    26/04/2014: WTO To Consider Five Australia Plain Packaging Disputes Under One Panel
    24/04/2014: Special Report: One Year On At The Medicines Patent Pool: Interview With Greg Perry
    23/04/2014: Geneva Health Forum Covers Wide Range Of Policy Issues
    22/04/2014: Panel Looks At Public Hospitals And Innovation
    11/04/2014: Geneva Health Forum Meets To Discuss Solutions To Common Problems
    11/04/2014: East African Community Moves To Harmonise IP Rights Regulation
    09/04/2014: WHO Guidelines May Help With Price Reductions For Hepatitis C Drugs
    08/04/2014: New South Africa IP Policy Unlikely Before May Elections
    07/04/2014: Global Fund And Tiered Medicines Pricing Under Debate
    04/04/2014: MPP Drug Licensing Deal Brings Hope For Greater Access To HIV Treatments
    04/04/2014: UNITAID Publishes Full Report On Health Implications Of TPP
    02/04/2014: Africa-EU Businesses, International Organisations Send Recommendations On Health To Leaders
    28/03/2014: Alternative Therapies, Incentive Models Eyed For Antibiotic Resistance
    27/03/2014: WHO Members Discuss Engagement With Non-State Actors This Week
    27/03/2014: Australia Accepts Indonesia WTO Dispute On Tobacco Packaging; Calls For Five Disputes To Be Joined
    24/03/2014: Analysis Shows Mixed Results On Big Pharma R&D Efforts For TB
    18/03/2014: Interview With Hans Hogerzeil: Recognising Good Practices Of Pharma
    14/03/2014: EU Parliament To Vote On Compulsory Publishing Of Clinical Trial Data
    13/03/2014: MakaPads Helping Disadvantaged Girls And Women In Uganda
    12/03/2014: Book Challenges ‘Neoliberal’ Approach In Global Public Health Policy
    07/03/2014: WHO Draft Guidelines On Sugars Intake
    05/03/2014: Intergovernmental South Centre Issues Statement On “US Attacks On Indian IP Policy”
    03/03/2014: WHO Bulletin Article On Local Pharmaceutical Manufacturing In Africa
    27/02/2014: TRIPS Council: Discussion Of IP And Innovation Irritates India: Other Issues Unchanged
    26/02/2014: IP Rights Impact Practice Of Science, Global Justice, Author Says
    26/02/2014: US Congress Committee Issues Report On “Highly Invasive” FDA Surveillance Of Employees
    26/02/2014: UNITAID Assesses Potential Implications Of Trans-Pacific Partnership Agreement
    25/02/2014: EU Trademark Reform Delayed; Debate Includes Goods-In-Transit, Harmonisation
    25/02/2014: Year Ahead: Biotech, IP Promise to Create Controversy From Farms To Big Pharma In 2014
    24/02/2014: Infojustice: Graphics Show Rise In US Pharma Exports To India, Patent Grants By India
    20/02/2014: Interview With Nazeem Mohamed, CEO Of Kampala Pharmaceutical Industries
    20/02/2014: TTIP: No Lowering Of Standards, Officials Say; New Trade Consultation Body Scrutinised
    20/02/2014: Tobacco Packaging, Green Tech, University IP On Plate Of WTO IP Committee
    19/02/2014: 3D Printing Will Cost The World USD100 Billion, Says Study
    18/02/2014: Battles Over Patents: Is India Changing The Rules Of The Game?
    17/02/2014: ICTSD Paper Makes Recommendations For Exhaustion Of IP Rights
    12/02/2014: Biopharma Industries, Others Urge Caution In US Patent Reform
    12/02/2014: WHO, IFRC Tap Swiss Federal Funds For New Buildings
    11/02/2014: DNDi Director: ‘Reality Check’ Needed For Neglected Diseases
    10/02/2014: Alert: Pharma IPR 2014 Conference In Mumbai, 26-28 February
    01/02/2014: WIPO Patent Law Committee Agrees On Studies, Seminars, Website Updates
    31/01/2014: MSF: AstraZeneca Pullout Of Neglected Disease R&D Proof System Broken
    31/01/2014: New Study Makes Case for Innovative Medicines
    Your IP address is 54.196.194.141